Friedrich Finckenstein compensation by year
IOVANCE BIOTHERAPEUTICS Summary Compensation Table · all 4 fiscal years held| Component | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Salary | $204,807 | $450,000 | $468,333 | $550,000 |
| Bonus | $160,000 | $0 | $0 | $188,000 |
| Stock awards | $0 | $0 | $940,001 | $522,788 |
| Option awards | $2,655,440 | $1,220,910 | $2,691,910 | $627,379 |
| Non-equity incentive | $82,500 | $90,000 | $169,200 | $308,000 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $11,200 | $11,400 | $11,600 | $12,200 |
| Total | $3,113,947 | $1,772,310 | $4,281,044 | $2,208,366 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IOVANCE BIOTHERAPEUTICS, INC. DEF 14A filed April 26, 2023, accession 0001558370-23-006895, and prior-year filings.
How this page was built: the IOVANCE BIOTHERAPEUTICS, INC. filed document, accession 0001558370-23-006895. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2023.
Equity holdings
unvested awards at FY2022 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 33,750 | $215,663 | — |
| Option | 41,669 | — | $46.26 |
| Option | 6,251 | — | $25.54 |
| Option | 67,500 | — | $15.49 |
Per the Outstanding Equity Awards at Fiscal Year-End table in IOVANCE BIOTHERAPEUTICS, INC.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.
IOVANCE BIOTHERAPEUTICS’s named executive officers, FY2022
as the company reported each| Named executive officer | Role | FY2022 total |
|---|---|---|
| Frederick Vogt | Interim President and Chief Executive Officer | $5,259,100 |
| Friedrich Finckenstein · this page | Chief Medical Officer | $2,208,366 |
| Jean-Marc Bellemin | Chief Financial Officer | $2,186,957 |
| Igor Bilinsky | Chief Operating Officer | $2,082,366 |
The full IOVANCE BIOTHERAPEUTICS compensation record
free company briefThis page is one person within IOVANCE BIOTHERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the IOVANCE BIOTHERAPEUTICS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IOVANCE BIOTHERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.